Goodwin Procter advised Citizens Financial Group, Inc. on the deal. Citizens Financial Group, Inc. (NYSE: CFG) announced its definitive agreement to acquire College Raptor, Inc. Citizens is...
Citizens Financial Group’s Acquisition of College Raptor
ACELYRIN’s $300 Million Series C Financing Round
Goodwin Procter advised ACELYRIN on the deal. ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation...
Nuwacell Biotechnologies’ Series A Financing Round
Goodwin Procter advised Legend Capital on the deal. Legend Capital announced its leading investment in Nuwacell Biotechnologies’ Series A financing round. Legend Capital is a private equity...
Alnylam Pharmaceuticals’ $1.035 Billion Notes Offering
Goodwin Procter advised Alnylam Pharmaceuticals, Inc. on the deal, while Davis Polk advised the representative of the initial purchasers. Alnylam Pharmaceuticals, Inc. announced its inaugural offering...
Genfit’s Acquisition of Versantis
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
SpringWorks Therapeutics’ $300 Million Shares Private Placement
Goodwin Procter advised SpringWorks Therapeutics on the deal. SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced its private placement transaction with a select group of institutional investors to issue...
Arcutis Biotherapeutics’ $400 Million Acquisition of Ducentis BioTherapeutics
Goodwin Procter advised Ducentis BioTherapeutics on the deal. Ducentis BioTherapeutics announced its acquisition by Arcutis Biotherapeutics for up to $400 million. Ducentis BioTherapeutics, a portfolio company of...
TIME’s Acquisition of Brandcast
Goodwin Procter advised TIME on the deal. TIME announced its acquisition of Brandcast, the leading no-code platform for creating and managing enterprise-grade websites. Through the acquisition, Brandcast’s...
Ampersand Capital Partners’ $1.2 Billion Closing of Latest Fund
Goodwin Procter advised Ampersand Capital Partners on the deal. Ampersand Capital Partners announced its first and only closing of Ampersand 2022 Limited Partnership with $1.2 billion in...
Stark’s $6 Million Seed Round
Goodwin Procter advised Uncork Capital on the deal. Uncork Capital acted as lead investor in Stark’s $6 million seed round. Also participating in the round were...
Novo Nordisk’s $1.1 Billion Acquisition of Forma Therapeutics
Davis Polk advised Novo Nordisk on the deal while Goodwin Procter represented Forma Therapeutics. Novo Nordisk announced its approximately $1.1 billion acquisition of Forma Therapeutics. Under the...
Sagard’s Acquisition of Novepan
Goodwin a conseillé Azulis Capital dans le cadre de la cession de Novepan. Le Management de Novepan était conseillé par Piotraut Giné Avocats. Sagard était conseillé...